The new long acting muscarinic antagonists for the treatment of COPD; empirical benefits compared with tiotropium.

The new long acting muscarinic antagonists for the treatment of COPD; empirical benefits compared with tiotropium.

Order Description
The new long acting muscarinic antagonists for the treatment of COPD (chronic obstructive pulmonory disease); empirical benefits compared with tiotropium.

find the cost of your paper